Privigen: Series of adverse reactions
Brand(s)
Last updated
Summary
Product
Privigen
Issue
Health products - Adverse reaction
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Privigen |
Privigen |
DIN 02304619 |
Liquid |
Immunoglobulin Intravenous (Human), 10% |
P100543004 |
Issue
Affected lot being voluntarily recalled due to a series of adverse reactions.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
CSL Behring Canada Inc.
1460- 55 Metcalfe Street
Ottawa, Ontario
K1P 6L5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74785
Get notified
Receive notifications for new and updated recalls and alerts by category.